These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5564861)

  • 1. [Progressive extra-pyramidal disorder in 2 young brothers. Remarkable effects of treatment with L-dopa].
    Castaigne P; Rondot P; Ribadeau-Dumas JL; Saïd G
    Rev Neurol (Paris); 1971 Feb; 124(2):162-6. PubMed ID: 5564861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the range of efficacy of L-dopa.
    Klawans HL
    Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V; Kemali D; Pacini A; Bertolino A; Lamura G
    Boll Soc Ital Biol Sper; 1971 Aug; 47(15):470-2. PubMed ID: 5158530
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa and amantadine hydrochloride in extra-pyramidal disorders.
    Parkes JD; Knill-Jones RP; Clements PJ
    Postgrad Med J; 1971 Feb; 47(544):116-9. PubMed ID: 5572526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of L-dopa in familial sporadic dystonia in children].
    Castaigne P; Rascol A; Rondot P; Ribadeau-Dumas JL; Géraud J; David J
    Rev Neurol (Paris); 1972 Aug; 127(2):317-20. PubMed ID: 4666642
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of L-Dopa in drug induced extrapyramidalism.
    Yaryura-Tobias JA; Wolpert A; Dana L; Merlis S
    Dis Nerv Syst; 1970 Jan; 31(1):60-3. PubMed ID: 5413729
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic trial of rigidity-akinesia in children using L-Dopa].
    Lombard M; Tardieu G
    Rev Neurol (Paris); 1973 Dec; 129(6):369. PubMed ID: 4603921
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complex encephalopathy in 2 brothers: its course under L-dopa].
    Thomas C; Rondot P; Ribadeau-Dumas JL; Raiser E
    Rev Otoneuroophtalmol; 1976; 48(3):155-9. PubMed ID: 973074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of extrapyramidal-motor symptoms. Drug treatment].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():697-704. PubMed ID: 5406928
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual arm movements with onset in childhood--a nosologic entity?
    Guggenheim MA; Dodge PR
    Trans Am Neurol Assoc; 1970; 95():182-6. PubMed ID: 5514363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Attempted treatment with L-dopa in motor disorders during prolonged coma].
    Bioulac B; Richer E
    Bord Med; 1971 Apr; 4(4):1175-8. PubMed ID: 5562248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiological aspects of cerebral motor disorders].
    Robănescu N; Bardoş H
    Pediatria (Bucur); 1972; 21(3):243-9. PubMed ID: 5066387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dystonias].
    Saïd G
    Nouv Presse Med; 1972 Feb; 1(8):527-32. PubMed ID: 4401063
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathogenetic significance of metabolic disorders in hereditary extrapyramial diseases].
    Tkachev RA; Markova ED; Gotovtseva EV; Bauman LK; Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):512-20. PubMed ID: 4250562
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-Dopa in the management of chronic manganese poisoning].
    Mena I; Court J; Fuenzalida S; Papavasiliou PS; Cotzias GC
    Rev Med Chil; 1969 Jun; 97(6):343-51. PubMed ID: 5379305
    [No Abstract]   [Full Text] [Related]  

  • 18. The reflexogenic extrapyramidal syndrome induced by sudden movement.
    Kishimoto K; Okada K
    Nagoya Med J; 1965 Oct; 11(2):101-20. PubMed ID: 5857456
    [No Abstract]   [Full Text] [Related]  

  • 19. [Considerations on hyperkinesis caused by L-dopa: significance of the biochemical deficit and anatomical deficit].
    Pinelli P
    Arch Psicol Neurol Psichiatr; 1970; 31(5):405-16. PubMed ID: 5502810
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.